JLL Income Property Trust (IPT) has fully subscribed its JLLX Ardenwood, DST offering. The two-property life sciences portfolio is located in Fremont, California and was structured as a Delaware Statutory Trust to provide 1031 exchange investors the opportunity to reinvest proceeds from the sale of appreciated real estate. With an estimated value of $90 million, this investment provides investors with a durable stream of income from Class A real estate leased to strong creditworthy tenants.
Allan Swaringen, President and CEO of JLL IPT commented on the offering: “Life science properties in the Bay Area are among those performing best within medical/healthcare sector due to high demand that surpasses supply. Wealth management firms and their property owner clients who participated in this offering saw great potential for quality real estate investments through our institutional management platform.”
